Evaluate qualified international options when a patient-specific request may have a viable pathway.
Patient-specific international access
Medication access can be more human.
When high costs, limited U.S. availability, or specialty handling create barriers, PharmaViaRx helps individuals explore a documented international pathway—one case, one human review, and one supported handoff at a time.
PharmaViaRx does not diagnose, prescribe, or guarantee product availability, savings, shipment admission, or delivery.
Choose your pathway
Built around the person who needs the medicine.
Individuals receive the clearest path in this first release. Employers and health plans can explore a separate program model for supported specialty access and responsible cost containment.
For individuals
Explore an access option without navigating the process alone.
Understand the evidence, review, sourcing, and fulfillment steps before you open a case.
For employers & plans
Add a supported path for high-cost specialty needs.
Review member support, governance, sourcing evaluation, and implementation considerations.
What guides every case
Access is meaningful only when trust travels with it.
Our operating principles shape how information is reviewed, how products are sourced, and how each handoff is supported.
Keep claims, evidence, decisions, and service boundaries clear and attributable.
Organize the process around the individual while preserving the treating clinician relationship.
Apply documented supplier, product, batch, packaging, and handling checks.
Plan traceable, supported handoffs appropriate to the product and approved route.
How it works
A controlled path from first question to supported handoff.
The case moves forward only when the information required for the next human review is present. A later step never guarantees the one after it.
Create your credential and open a support case.
LiveAgent provides the MVP account, case-entry ticket, and support correspondence.
Identify the request and required documentation.
A valid prescription, treating-clinician information, identity, address, and personal-use evidence may be required through an approved secure channel.
Receive an attributable eligibility outcome.
Reviewers assess the case, sourcing feasibility, quality conditions, and applicable boundaries. Automated approval is not used.
Review next steps, quote, and supported delivery.
If the case can proceed, fulfillment preparation, tracking, and support follow. Government authorities retain final admissibility.
Medication categories
Focused where access and handling are most complex.
The public site offers category education—not a catalog. Patients identify a request with their treating clinician; product eligibility and availability are reviewed case by case.
GLP-1 class therapies
Educational information about semaglutide- and tirzepatide-based requests, prescription evidence, and product-specific handling.
Understand the categoryTemperature-controlled products
Items whose storage and transport require qualified packaging, route planning, monitoring, and excursion procedures.
Review cold-chain controlsSpecialty access
Patient-specific requests involving complex sourcing, documentation, distribution, or support requirements.
Explore specialty accessSourcing and quality
International reach with documented checkpoints.
Approved region-level sources are evaluated against applicable licensing and quality requirements. Named partners, countries, carriers, or performance claims are published only after verification.
Supplier qualification
Confirm identity, authorization, scope, and approved quality status before case-specific sourcing.
Product evidence
Review product identity, batch, expiry, packaging, and traceability records appropriate to the case.
Handling plan
Match preparation, packaging, route, and monitoring controls to the product’s approved requirements.
Supported handoff
Maintain tracking, documented exceptions, escalation, and patient support through the planned journey.
Personal importation
Enforcement discretion is not advance permission.
FDA states that importing prescription medicines into the United States is illegal in most circumstances. Its personnel may consider enforcement discretion in narrow situations based on the facts and evidence presented.
FDA, U.S. Customs and Border Protection, and other competent authorities may inspect, detain, or refuse a shipment. Controlled substances and other regulated categories may involve additional authorities.
Employers and health plans
A governed option for specialty-access conversations.
Explore a program model that supports member education, case coordination, clinical independence, sourcing evaluation, and responsible oversight. Potential savings are case-specific and never guaranteed.
Our mission
Experience across the handoffs that matter.
Pharmacy, PBM, quality, regulatory, and international logistics perspectives inform a patient-focused operating model.
Questions before a case
Start with clear answers.
These answers describe the public MVP. The canonical support library will move to the verified LiveAgent Knowledge Base when production configuration is approved.
Does PharmaViaRx prescribe medication?
No. PharmaViaRx does not diagnose, prescribe, or replace your treating clinician. A valid prescription and clinician information may be required for case review.
Can you guarantee that my requested medicine is available or less expensive?
No. Availability, eligibility, source, timing, and cost are assessed case by case. Public category examples are educational and are not offers or recommendations.
Does opening a case mean FDA has approved an import?
No. FDA personal-importation guidance describes narrow circumstances in which personnel may consider enforcement discretion. It is not an approval program or a guarantee of admission.
What can I do in the MVP portal?
You can create a credential, open a case-entry ticket, and correspond with support once the production LiveAgent portal is approved. Full prescription, order-history, profile, and payment management are not represented as live MVP features.
A supported first step
Begin with a question. Move forward only with evidence.
Use the secure case portal when it becomes available for approved intake. For now, email general, non-clinical questions without including health, identity, prescription, or payment information.